Boston Scientific Boosts Heart Biz With $1.75B Baylis Buy
Boston Scientific, advised by Shearman & Sterling, has agreed to pay $1.75 billion to pick up Montreal-based Baylis Medical, represented by BCF Business Law and Cooley, in a deal that serves...To view the full article, register now.
Already a subscriber? Click here to view full article